Evidence map›Paper›PMID 24720953›Full record

ArticleThe American journal of pathology2014

Laminin α1 regulates age-related mesangial cell proliferation and mesangial matrix accumulation through the TGF-β pathway.

Liang Ning, Hidetake Kurihara, Susana de Vega, Naoki Ichikawa-Tomikawa, Zhuo Xu, Risa Nonaka, Saiko Kazuno, Yoshihiko Yamada, Jeffrey H Miner, Eri Arikawa-Hirasawa

Open access · bronzeAbstract read
In one paragraph

Article in The American journal of pathology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Laminin-111 Improves the Anabolic Response to Mechanical Load in Aged Skeletal Muscle.The journals of gerontology. Series A, Biological sciences and medical sciences · 2021
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Liang NingResearch Institute for Diseases of Old Age, BioMedical Research Center, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Hidetake KuriharaDepartment of Anatomy and Life Structure, BioMedical Research Center, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Susana de VegaResearch Institute for Diseases of Old Age, BioMedical Research Center, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Naoki Ichikawa-TomikawaResearch Institute for Diseases of Old Age, BioMedical Research Center, Juntendo University Graduate School of Medicine, Tokyo, Japan; Department of Basic Pathology, Fukushima Medical University School of Medicine, Fukushima, Japan.
Zhuo XuResearch Institute for Diseases of Old Age, BioMedical Research Center, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Risa NonakaResearch Institute for Diseases of Old Age, BioMedical Research Center, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Saiko KazunoDivision of Proteomics and Biomolecular Science, BioMedical Research Center, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Yoshihiko YamadaNational Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland.
Jeffrey H MinerRenal Division, Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri.
Eri Arikawa-HirasawaResearch Institute for Diseases of Old Age, BioMedical Research Center, Juntendo University Graduate School of Medicine, Tokyo, Japan; Department of Neurology, BioMedical Research Center, Juntendo University Graduate School of Medicine, Tokyo, Japan. Electronic address: ehirasaw@juntendo.ac.jp.
Juntendo University · JPFukushima Medical University · JPNational Institutes of Health · USWashington University in St. Louis · US

Funding

Basement Membranes and Associated Protein Factors In Development and DiseaseZIADE000485 · NIDCR · NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH · PI YAMADA, YOSHIHIKO · 2009 to 2017
$5.9M
LAMININS AND GLOMERULAR FILTRATIONR01DK078314 · NIDDK · WASHINGTON UNIVERSITY · PI MINER, JEFFREY H · 2008 to 2021
$5.4M
Intramural NIH HHSNIDDK NIH HHS R01 DK078314NIDDK NIH HHS R01DK078314
6 · The paper itself

Abstract

Laminin α1 (LAMA1), a subunit of the laminin-111 basement membrane component, has been implicated in various biological functions in vivo and in vitro. Although LAMA1 is present in kidney, its roles in the kidney are unknown because of early embryonic lethality. Herein, we used a viable conditional knockout mouse model with a deletion of Lama1 in the epiblast lineage (Lama1(CKO)) to study the role of LAMA1 in kidney development and function. Adult Lama1(CKO) mice developed focal glomerulosclerosis and proteinuria with age. In addition, mesangial cell proliferation was increased, and the mesangial matrix, which normally contains laminin-111, was greatly expanded. In vitro, mesangial cells from Lama1(CKO) mice exhibited significantly increased proliferation compared with those from controls. This increased proliferation was inhibited by the addition of exogenous LAMA1-containing laminin-111, but not by laminin-211 or laminin-511, suggesting a specific role for LAMA1 in regulating mesangial cell behavior. Moreover, the absence of LAMA1 increased transforming growth factor (TGF)-β1-induced Smad2 phosphorylation, and inhibitors of TGF-β1 receptor I kinase blocked Smad2 phosphorylation in both control and Lama1(CKO) mesangial cells, indicating that the increased Smad2 phosphorylation occurred in the absence of LAMA1 via the TGF-β1 receptor. These findings suggest that LAMA1 plays a critical role in kidney function and kidney aging by regulating the mesangial cell population and mesangial matrix deposition through TGF-β/Smad signaling.

Indexed as

Cell ProliferationAgingAnimalsExtracellular MatrixGlomerular MesangiumGlomerulonephritisLamininMiceMice, KnockoutPhosphorylationProteinuriaSignal TransductionSmad2 ProteinTransforming Growth Factor beta1Lamininlaminin ASmad2 ProteinSmad2 protein, mouseTgfb1 protein, mouseTransforming Growth Factor beta1

Identifiers

PMID24720953
PMCPMC4044709
OpenAlexW2147094935

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.